BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30503048)

  • 21. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
    Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection.
    Chen JL; Lin XJ; Zhou Q; Shi M; Li SP; Lao XM
    Chin J Cancer; 2016 Mar; 35():28. PubMed ID: 26992891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma.
    Li C; Li ZC; Ma L; Li LQ; Zhong JH; Xiang BD; Gong WF
    Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):749-756. PubMed ID: 32552297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis.
    Xu M; Zhou Z; Xu R; Zhang H; Lin N; Zhong Y
    World J Surg Oncol; 2019 Mar; 17(1):45. PubMed ID: 30823932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Actual 10-Year Survival After Hepatectomy of HBV-Related Hepatocellular Carcinoma: a Multicenter Study.
    Li ZL; Yan WT; Zhang J; Zhao YJ; Lau WY; Mao XH; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Wu H; Li C; Wang MD; Wu MC; Shen F; Yang T
    J Gastrointest Surg; 2019 Feb; 23(2):288-296. PubMed ID: 30334177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of intrahepatic hepatitis B DNA and covalently closed circular DNA on survival after hepatectomy in HBV-associated hepatocellular carcinoma patients.
    Wang Q; Fiel MI; Luan W; Blank S; Kadri H; Kim KW; Hiotis SP
    Ann Surg Oncol; 2013 Nov; 20(12):3761-70. PubMed ID: 23771248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative Controlling Nutritional Status Score Predicts Mortality after Hepatectomy for Hepatocellular Carcinoma.
    Takagi K; Umeda Y; Yoshida R; Nobuoka D; Kuise T; Fushimi T; Fujiwara T; Yagi T
    Dig Surg; 2019; 36(3):226-232. PubMed ID: 29672297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative controlling nutritional status (CONUT) score predicts long-term outcomes in patients with non-B non-C hepatocellular carcinoma after curative hepatic resection.
    Tsunematsu M; Haruki K; Fujiwara Y; Furukawa K; Onda S; Matsumoto M; Gocho T; Shiba H; Yanaga K
    Langenbecks Arch Surg; 2021 Feb; 406(1):99-107. PubMed ID: 32936328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Controlling Nutritional Status plus Tumor Burden Score for the Assessment of Prognosis after Curative Liver Resection for Hepatocellular Carcinoma.
    Fukami Y; Saito T; Osawa T; Arikawa T; Matsumura T; Kurahashi S; Komatsu S; Kaneko K; Sano T
    Med Princ Pract; 2021; 30(2):131-137. PubMed ID: 33361696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma.
    Gong WF; Zhong JH; Lu SD; Wang XB; Zhang QM; Ma L; Zhang ZM; Xiang BD; Li LQ
    Oncotarget; 2017 Feb; 8(9):15047-15056. PubMed ID: 28122361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of HBV DNA in the hepatic parenchyma from patients with non-B, non-C hepatocellular carcinoma.
    Nakai T; Shiraishi O; Kawabe T; Ota H; Nagano H; Shiozaki H
    World J Surg; 2006 Jul; 30(7):1338-43. PubMed ID: 16773264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of the controlling nutritional status (CONUT) score in patients undergoing hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
    Takagi K; Domagala P; Polak WG; Buettner S; Ijzermans JNM
    BMC Gastroenterol; 2019 Dec; 19(1):211. PubMed ID: 31818259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
    Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
    Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib.
    Lim S; Han J; Kim GM; Han KH; Choi HJ
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1024-31. PubMed ID: 25611175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy?
    Yu LH; Li N; Shi J; Guo WX; Wu MC; Cheng SQ
    Ann Surg Oncol; 2014 Mar; 21(3):1010-5. PubMed ID: 24121884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma.
    Huang S; Xia Y; Lei Z; Zou Q; Li J; Yang T; Wang K; Yan Z; Wan X; Shen F
    J Am Coll Surg; 2017 Mar; 224(3):283-293.e4. PubMed ID: 27923614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy.
    Jang JW
    World J Gastroenterol; 2014 Jun; 20(24):7675-85. PubMed ID: 24976705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.